23-Jan-2026
MetLife to Hold Combined Earnings and Outlook Conference Call
Business Wire (Wed, 7-Jan 4:15 PM ET)
New MetLife Data Finds Rising Cost Pressures Outpacing Gains in Workforce Well-Being
Business Wire (Wed, 7-Jan 9:00 AM ET)
MetLife Declares First Quarter 2026 Common Stock Dividend
Business Wire (Tue, 6-Jan 4:15 PM ET)
MetLife Investment Management Completes Acquisition of PineBridge Investments
Business Wire (Tue, 30-Dec 5:15 AM ET)
MetLife Pet Insurance Collaborates with Petstablished to Make Pet Coverage Easy at Adoption
Business Wire (Wed, 17-Dec 9:41 AM ET)
Business Wire (Mon, 8-Dec 9:00 AM ET)
MetLife Completes $10 Billion Variable Annuity Risk Transfer Transaction
Business Wire (Mon, 1-Dec 4:15 PM ET)
FIFA Global Citizen Education Fund Opens Grant Applications for Grassroots Organizations Worldwide
Business Wire (Fri, 21-Nov 2:18 AM ET)
MetLife Declares Fourth Quarter 2025 Preferred Stock Dividends
Business Wire (Mon, 17-Nov 4:15 PM ET)
MetLife Celebrated as a Top 25 Fortune World's Best Workplace 2025
Business Wire (Thu, 13-Nov 9:35 AM ET)
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
Metlife trades on the NYSE stock market under the symbol MET.
As of January 23, 2026, MET stock price declined to $75.81 with 3,210,596 million shares trading.
MET has a beta of 1.06, meaning it tends to be more sensitive to market movements. MET has a correlation of 0.51 to the broad based SPY ETF.
MET has a market cap of $49.95 billion. This is considered a Large Cap stock.
Last quarter Metlife reported $18 billion in Revenue and $2.37 earnings per share. This fell short of revenue expectation by $-849 million and exceeded earnings estimates by $.05.
In the last 3 years, MET traded as high as $89.05 and as low as $48.95.
The top ETF exchange traded funds that MET belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
MET has underperformed the market in the last year with a price return of -10.0% while the SPY ETF gained +14.2%. MET has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -2.3% and -4.5%, respectively, while the SPY returned +2.9% and -0.7%, respectively.
MET support price is $75.80 and resistance is $78.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MET shares will trade within this expected range on the day.